null

SMILES: CS(=O)(=O)c1ccccc1-c1ccc(N2CCCC(NC(=O)Nc3ccc(Cl)nn3)C2=O)c(F)c1

InChI Key: InChIKey=RRHKDWDUKORDOC-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 454180   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454180 (US10717708, Example 27 | US11186544, Example 27) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CCCC(NC(=O)Nc3ccc(Cl)nn3)C2=O)c(F)c1 Show InChI InChI=1S/C23H21ClFN5O4S/c1-35(33,34)19-7-3-2-5-15(19)14-8-9-18(16(25)13-14)30-12-4-6-17(22(30)31)26-23(32)27-21-11-10-20(24)28-29-21/h2-3,5,7-11,13,17H,4,6,12H2,1H3,(H2,26,27,29,32)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	400	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454180 (US10717708, Example 27 | US11186544, Example 27) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CCCC(NC(=O)Nc3ccc(Cl)nn3)C2=O)c(F)c1 Show InChI InChI=1S/C23H21ClFN5O4S/c1-35(33,34)19-7-3-2-5-15(19)14-8-9-18(16(25)13-14)30-12-4-6-17(22(30)31)26-23(32)27-21-11-10-20(24)28-29-21/h2-3,5,7-11,13,17H,4,6,12H2,1H3,(H2,26,27,29,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	950	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454180 (US10717708, Example 27 | US11186544, Example 27) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CCCC(NC(=O)Nc3ccc(Cl)nn3)C2=O)c(F)c1 Show InChI InChI=1S/C23H21ClFN5O4S/c1-35(33,34)19-7-3-2-5-15(19)14-8-9-18(16(25)13-14)30-12-4-6-17(22(30)31)26-23(32)27-21-11-10-20(24)28-29-21/h2-3,5,7-11,13,17H,4,6,12H2,1H3,(H2,26,27,29,32)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	400	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454180 (US10717708, Example 27 | US11186544, Example 27) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CCCC(NC(=O)Nc3ccc(Cl)nn3)C2=O)c(F)c1 Show InChI InChI=1S/C23H21ClFN5O4S/c1-35(33,34)19-7-3-2-5-15(19)14-8-9-18(16(25)13-14)30-12-4-6-17(22(30)31)26-23(32)27-21-11-10-20(24)28-29-21/h2-3,5,7-11,13,17H,4,6,12H2,1H3,(H2,26,27,29,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	950	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair